These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36438615)

  • 1. High Level of Pretreatment and Acquired Human Immunodeficiency Virus Drug Resistance in El Salvador: A Nationally Representative Survey, 2018-2019.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Quezada A; Ruiz L; Arguera N; Sorto S; Nieto AI; Tapia-Trejo D; López-Sánchez DM; Pérez-García M; Cruz L; Andino R; Sajquim E; Juárez SI; Farach N; Ravasi G; Northbrook S; Reyes-Terán G; Ávila-Ríos S
    Open Forum Infect Dis; 2022 Nov; 9(11):ofac580. PubMed ID: 36438615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
    J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level of pre-treatment and acquired HIV drug resistance in Honduras: a nationally representative survey, 2016-17.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Meza RI; Sierra T; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Paredes M; Rodríguez A; Juárez SI; Farach N; Videa G; Lara B; Rodríguez E; Ardón E; Sajquim E; Lorenzana R; Ravasi G; Northbrook S; Reyes-Terán G; Ávila-Ríos S
    J Antimicrob Chemother; 2020 Jul; 75(7):1932-1942. PubMed ID: 32303063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda.
    Ssemwanga D; Asio J; Watera C; Nannyonjo M; Nassolo F; Lunkuse S; Salazar-Gonzalez JF; Salazar MG; Sanyu G; Lutalo T; Kabuga U; Ssewanyana I; Namatovu F; Namayanja G; Namale A; Raizes E; Kaggwa M; Namuwenge N; Kirungi W; Katongole-Mbidde E; Kaleebu P;
    J Antimicrob Chemother; 2020 May; 75(5):1280-1289. PubMed ID: 32025714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017-2018.
    Dat VQ; Anh NTL; Van Nghia K; Linh NT; Thu HHK; Tam TTM; Ton T; Anh LQ; Phuc ND; Huong PTT; Nhan DT; Hai NH; Bertagnolio S; Crisp AM; Inzaule S; Dean NE; Jordan MR; Nguyen VTT
    J Int AIDS Soc; 2022 Feb; 25(2):e25857. PubMed ID: 35194954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey.
    Ávila-Ríos S; García-Morales C; Matías-Florentino M; Romero-Mora KA; Tapia-Trejo D; Quiroz-Morales VS; Reyes-Gopar H; Ji H; Sandstrom P; Casillas-Rodríguez J; Sierra-Madero J; León-Juárez EA; Valenzuela-Lara M; Magis-Rodríguez C; Uribe-Zuñiga P; Reyes-Terán G;
    Lancet HIV; 2016 Dec; 3(12):e579-e591. PubMed ID: 27658867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral load suppression and acquired HIV drug resistance in adults receiving antiretroviral therapy in Viet Nam: results from a nationally representative survey.
    Dat VQ; Duong BD; Nhan DT; Hai NH; Anh NTL; Thu HHK; Ton T; Anh LQ; Nghia NT; Thuong NV; Nghia KV; Tam TTM; Hau TP; Phuc ND; Thinh VX; Hien NT; Lien TTX; Bertagnolio S; Van NTT; Kato M
    Western Pac Surveill Response J; 2018; 9(3):16-24. PubMed ID: 30377546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment HIV drug resistance among adults initiating ART in Namibia.
    Taffa N; Roscoe C; Sawadogo S; De Klerk M; Baughman AL; Wolkon A; Mutenda N; DeVos J; Zheng DP; Wagar N; Prybylski D; Yang C; Hamunime N; Agolory S; Raizes E
    J Antimicrob Chemother; 2018 Nov; 73(11):3137-3142. PubMed ID: 30137412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment HIV Drug Resistance Among Adults Initiating or Re-Initiating First-Line Antiretroviral Therapy in Zimbabwe: Fast-Tracking the Transition to Dolutegravir-Based First-Line Regimens?
    Kouamou V; Mavetera J; Manasa J; Ndhlovu CE; Katzenstein D; McGregor AM
    AIDS Res Hum Retroviruses; 2021 Oct; 37(10):776-783. PubMed ID: 33430681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Drug Resistance in Antiretroviral Treatment-Naïve Individuals in the Largest Public Hospital in Nicaragua, 2011-2015.
    Avila-Ríos S; García-Morales C; Matías-Florentino M; Tapia-Trejo D; Hernández-Álvarez BF; Moreira-López SE; Quant-Durán CJ; Porras-Cortés G; Reyes-Terán G
    PLoS One; 2016; 11(10):e0164156. PubMed ID: 27736898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Drug Resistance in Adults Initiating or Reinitiating Antiretroviral Therapy in Uruguay-Results of a Nationally Representative Survey, 2018-2019.
    Flieller R; Cabrera S; Ruchansky D; Girón-Callejas A; Brasesco M; Pérez D; Chiparelli H; García-Morales C; Tapia-Trejo D; Monreal-Flores J; Ravasi G; Jordan MR; Ávila-Ríos S
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial.
    Chung MH; McGrath CJ; Beck IA; Levine M; Milne RS; So I; Andersen N; Dross S; Coombs RW; Chohan B; Yatich N; Kiptinness C; Sakr SR; Kiarie JN; Frenkel LM
    Lancet HIV; 2020 Feb; 7(2):e104-e112. PubMed ID: 31818716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV drug resistance in persons initiating or reinitiating first-line antiretroviral therapy in Paraguay: Results of a National Patient Survey.
    Aguilar G; Truong HM; Ovelar P; Samudio T; Lopez G; García-Morales C; Tapia-Trejo D; López-Sánchez DM; Ávila-Ríos S; Giron A; De Arias AR; Rios-Gonzalez C; McFarland W
    J Med Virol; 2022 Oct; 94(10):5061-5065. PubMed ID: 35701340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of viral load suppression and acquired drug resistance among people living with HIV in Nepal: a nationally representative surveillance study.
    Deuba K; Panta G; Rajbhandari RM; Kunwar R; Pokhrel TN; Pandey LR; Changsom D; Saeng-Aroon S; Thakur SK
    J Glob Antimicrob Resist; 2023 Dec; 35():122-127. PubMed ID: 37709138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.
    Hong SY; Jonas A; DeKlerk M; Shiningavamwe A; Desta T; Badi A; Morris L; Hunt GM; Ledwaba J; Sheehan HB; Lau K; Trotter A; Tang AM; Wanke C; Jordan MR
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):463-71. PubMed ID: 25564107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon.
    Tchouwa GF; Eymard-Duvernay S; Cournil A; Lamare N; Serrano L; Butel C; Bertagnolio S; Mpoudi-Ngole E; Raizes E; Aghokeng AF;
    EClinicalMedicine; 2018 Jul; 1():21-27. PubMed ID: 31193678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
    Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
    Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of HIV drug resistance in low- and middle-income countries and WHO global strategy to monitor its emergence.
    Bertagnolio S; Jordan MR; Giron A; Inzaule S
    Curr Opin HIV AIDS; 2022 Jul; 17(4):229-239. PubMed ID: 35762378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia.
    Jordan MR; Hamunime N; Bikinesi L; Sawadogo S; Agolory S; Shiningavamwe AN; Negussie T; Fisher-Walker CL; Raizes EG; Mutenda N; Hunter CJ; Dean N; Steegen K; Kana V; Carmona S; Yang C; Tang AM; Parkin N; Hong SY
    Medicine (Baltimore); 2020 Sep; 99(37):e21661. PubMed ID: 32925712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment drug resistance among patients initiating antiretroviral therapy (ART) in Zimbabwe: 2008-2010.
    Mungati M; Mhangara M; Gonese E; Mugurungi O; Dzangare J; Ngwende S; Musasa P; Wellington M; Shambira G; Apollo T; Yang C; DeVos J; Sabatier J; Kilmarx P; Chakanyuka-Musanhu C; Tshimanga M
    BMC Res Notes; 2016 Jun; 9():302. PubMed ID: 27287672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.